PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Update

PURE Bioscience, Inc. (OTCMKTS:PURE) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 4,400 shares, a growth of 1,000.0% from the December 15th total of 400 shares. Based on an average daily volume of 233,200 shares, the short-interest ratio is presently 0.0 days.

PURE Bioscience Price Performance

Shares of OTCMKTS:PURE traded up $0.01 on Monday, reaching $0.09. 148,184 shares of the company traded hands, compared to its average volume of 107,414. PURE Bioscience has a fifty-two week low of $0.06 and a fifty-two week high of $0.16. The company’s 50 day moving average is $0.09 and its 200-day moving average is $0.08. The stock has a market capitalization of $10.07 million, a PE ratio of -2.25 and a beta of 0.07.

PURE Bioscience (OTCMKTS:PURE) last announced its quarterly earnings data on Monday, December 16th. The company reported ($0.01) EPS for the quarter.

About PURE Bioscience

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.